labetalol has been researched along with Urinary Bladder, Neurogenic in 1 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Urinary Bladder, Neurogenic: Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with labetalol was only partially successful in controlling the elevated blood pressure." | 1.32 | Autonomic dysreflexia manifested by severe hypertension. ( Assadi, F; Czech, K; Palmisano, JL, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assadi, F | 1 |
| Czech, K | 1 |
| Palmisano, JL | 1 |
1 other study available for labetalol and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Autonomic dysreflexia manifested by severe hypertension.
Topics: Adult; Antihypertensive Agents; Autonomic Dysreflexia; Blood Pressure; Drainage; Humans; Hypertensio | 2004 |